Tafero EM Tablet contains Emtricitabine and Tenofovir Alafenamide, two powerful antiretroviral medicines used for the treatment and prevention of HIV-1 infection. It helps reduce the amount of HIV in the blood, improves immune function, and lowers the risk of developing HIV-related complications. According to trusted sources like the Mayo Clinic and Drugs.com, this combination therapy is widely recommended in HIV management and prevention, including pre-exposure prophylaxis (PrEP).

Key Benefits & Uses

• Helps control HIV-1 infection by lowering viral load.

• Boosts immune response to fight infections more effectively.

• Reduces the risk of HIV-related complications such as opportunistic infections and certain cancers.

• Can be prescribed as part of PrEP to prevent HIV transmission in high-risk individuals, as approved by the FDA.

• Supports long-term treatment with better safety outcomes compared to older formulations, as highlighted on PubMed.

How to Use

• Take Tafero EM Tablet exactly as prescribed by your healthcare provider.

• Usually taken once daily with food.

• Do not skip doses, as missed treatment can reduce effectiveness and increase resistance.

• For complete details, check professional medical advice at WebMD or Healthline.

Important Safety Information

• Not a cure for HIV—continue practicing safe sex and avoid sharing personal items to prevent transmission.

• Regular monitoring of liver, kidney, and bone health is necessary.

• Inform your doctor if you have pre-existing renal or hepatic conditions.

• Always consult a healthcare professional before starting or stopping medication. More detailed guidelines are available at the WHO.

Common Side Effects

• Headache

• Nausea

• Fatigue

• Diarrhea

• Mild weight gain
  Most side effects are temporary, but seek immediate medical help if you notice signs of lactic acidosis or severe liver problems. For a detailed list of side effects, visit Drugs.com and Mayo Clinic.

Why Choose Tafero EM Tablet?

• Clinically proven combination therapy supported by international HIV guidelines.

• Offers improved safety and tolerability compared to older tenofovir formulations.

• Widely trusted in both treatment and prevention strategies.

• Recommended by top health authorities like the FDA, WHO, and published research on PubMed.